Literature DB >> 1848580

Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected.

D S Krause1, C Deutsch.   

Abstract

Using purified human T lymphocytes stimulated in serum-free media with adhered anti-CD3 + exogenous IL-2, we have shown that elevated [cAMP]i (mimicked by CPT-cAMP or induced by the physiological agonist PGE2) directly inhibits mitogen-induced 1) [3H]thymidine incorporation by PBMC, purified T cells, and isolated CD4+ and CD8+ T cell subpopulations; 2) expression of both high- and low-affinity IL-2 receptors; 3) plasma membrane expression of both p55 and p75 subunits of the IL-2 receptor; and 4) expression of p55 mRNA, but not p75 mRNA. The decrease in p55 mRNA is not due to enhanced mRNA metabolism. We conclude that elevated [cAMP]i, acting directly on T cells, inhibits mitogenesis by decreasing IL-2 receptor expression. We discuss the possible physiological relevance for the multiple stages of T cell activation that are sensitive to elevated [cAMP]i.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848580

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Differential expression of guanine nucleotide-binding proteins enhances cAMP synthesis in regenerating rat liver.

Authors:  A M Diehl; S Q Yang; D Wolfgang; G Wand
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

Review 2.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

3.  Phosphodiesterase 4B is essential for T(H)2-cell function and development of airway hyperresponsiveness in allergic asthma.

Authors:  S-L Catherine Jin; Sho Goya; Susumu Nakae; Dan Wang; Matthew Bruss; Chiaoyin Hou; Dale Umetsu; Marco Conti
Journal:  J Allergy Clin Immunol       Date:  2010-11-03       Impact factor: 10.793

4.  Cyclic AMP suppresses interleukin-5 synthesis by human helper T cells via the downregulation of the calcium mobilization pathway.

Authors:  O Kaminuma; A Mori; K Ogawa; H Kikkawa; A Nakata; K Ikezawa; H Okudaira
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

Review 5.  Neuroendocrine regulation of inflammation.

Authors:  Caroline J Padro; Virginia M Sanders
Journal:  Semin Immunol       Date:  2014-01-31       Impact factor: 11.130

6.  Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2.

Authors:  M A Giembycz; C J Corrigan; J Seybold; R Newton; P J Barnes
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

Review 7.  Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

8.  Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination.

Authors:  L Elliott; W Brooks; T Roszman
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

9.  IL-2 regulation of soluble IL-2 receptor levels following thermal injury.

Authors:  J A Teodorczyk-Injeyan; B G Sparkes; S Lalani; W J Peters; G B Mills
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

10.  Altered gene transcription after burn injury results in depressed T-lymphocyte activation.

Authors:  A F Horgan; M V Mendez; D S O'Riordain; R G Holzheimer; J A Mannick; M L Rodrick
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.